A simulation study found that five of six Shigella vaccine trial designs could underestimate efficacy, particularly in high-burden settings with rapidly acquired natural immunity.

A pair of marine scientists at the University of Antwerp, in Belgium, working with a colleague from the University of Otago, in New Zealand, have found that simulations they created showed that ...